Cover Image

Design, Synthesis, and Biological Evaluation of 2-Anilino-4-Triazolpyrimidine Derivatives as CDK4/HDACs Inhibitors

Suhua Wang,1,2 Siyuan Han,1,2 Weiyan Cheng,1,2 Ruoyang Miao,1,2 Shasha Li,1,2 Xin Tian,1,2 Quancheng Kan1,2 1Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450052, People's Republic of China; 2Henan Key Laboratory of Precision Clinical Pharmacy,...

Full description

Saved in:

Bibliographic Details
Main Authors:	Wang S (Author), Han S (Author), Cheng W (Author), Miao R (Author), Li S (Author), Tian X (Author), Kan Q (Author)
Format:	Book
Published:	Dove Medical Press, 2022-04-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Design, Synthesis and Biological Investigation of 2-Anilino Triazolopyrimidines as Tubulin Polymerization Inhibitors with Anticancer Activities
by: Romeo Romagnoli, et al.
Published: (2022)

Design, synthesis and biological evaluation of 2,4-pyrimidinediamine derivatives as ALK and HDACs dual inhibitors for the treatment of ALK addicted cancer
by: Dafeng Guo, et al.
Published: (2022)

Design, synthesis and biological evaluation of 2-((4-sulfamoylphenyl)amino)-pyrrolo[2,3-d]pyrimidine derivatives as CDK inhibitors
by: Bo Yang, et al.
Published: (2023)

Anilino-1,4-naphthoquinones as potent mushroom tyrosinase inhibitors: in vitro and in silico studies
by: Sahachai Sabuakham, et al.
Published: (2024)

Synthesis and Biological Evaluation of Highly Active 7-Anilino Triazolopyrimidines as Potent Antimicrotubule Agents
by: Paola Oliva, et al.
Published: (2022)

Design, synthesis and biological evaluation of novel histone deacetylase (HDAC) inhibitors derived from β-elemene scaffold
by: Yuan Gao, et al.
Published: (2023)

Synthesis and biological activity of bisindole derivatives as novel MARK4 inhibitors
by: Maria Voura, et al.
Published: (2022)

Design, Synthesis, and Evaluation of Benzoheterocyclic-Containing Derivatives as Novel HDAC1 Inhibitors
by: Min-Ru Jiao, et al.
Published: (2022)

Rational drug design, synthesis, and biological evaluation of novel chiral tetrahydronaphthalene-fused spirooxindole as MDM2-CDK4 dual inhibitor against glioblastoma
by: Biao Wang, et al.
Published: (2020)

Structure-Based Identification of Novel Histone Deacetylase 4 (HDAC4) Inhibitors
by: Rupesh Agarwal, et al.
Published: (2024)

Design, Synthesis and Biological Evaluation of New HDAC1 and HDAC2 Inhibitors Endowed with Ligustrazine as a Novel Cap Moiety
by: Al-Sanea MM, et al.
Published: (2020)

Design, Synthesis and Biological Evaluation of 1,4-Benzenesulfonamide Derivatives as Glyoxalase I Inhibitors
by: Audat SA, et al.
Published: (2022)

Design, Synthesis, In Vitro Anticancer Evaluation and Molecular Modelling Studies of 3,4,5-Trimethoxyphenyl-Based Derivatives as Dual EGFR/HDAC Hybrid Inhibitors
by: Tarek S. Ibrahim, et al.
Published: (2021)

Identification of 3-(piperazinylmethyl)benzofuran derivatives as novel type II CDK2 inhibitors: design, synthesis, biological evaluation, and in silico insights
by: Wagdy M. Eldehna, et al.
Published: (2022)

Mechanisms of CDK4/6 Inhibitor Resistance in Luminal Breast Cancer
by: Zhen Li, et al.
Published: (2020)

CDK4/6 inhibitors in advanced breast cancer, what is beyond?
by: Amrallah A. Mohammed, et al.
Published: (2019)

Bioorganometallic derivatives of 4-hydrazino-benzenesulphonamide as carbonic anhydrase inhibitors: synthesis, characterisation and biological evaluation
by: Jeremie Brichet, et al.
Published: (2020)

Design, Synthesis, and Biological Evaluation of Dual c-Met/HDAC Inhibitors Bearing 2-Aminopyrimidine Scaffold
by: Qingwei Zhang, et al.
Published: (2020)

Design, Synthesis, and Biological Evaluation of Dual c-Met/HDAC Inhibitors Bearing 2-Aminopyrimidine Scaffold
by: Qingwei Zhang, et al.
Published: (2020)

Design and synthesis of triazolopyridine derivatives as potent JAK/HDAC dual inhibitors with broad-spectrum antiproliferative activity
by: Zhengshui Xu, et al.
Published: (2024)

Design, synthesis and biological evaluation of pyrazolo[3,4-d]pyridazinone derivatives as covalent FGFR inhibitors
by: Xiaowei Wu, et al.
Published: (2021)

Efficient Synthesis and Docking Analysis of Selective CDK9 Inhibitor NVP-2
by: Abdusaid Saidahmatov, et al.
Published: (2021)

Synthesis, biological evaluation, and in silico studies of new CDK2 inhibitors based on pyrazolo[3,4-d]pyrimidine and pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine scaffold with apoptotic activity
by: Asmaa A. Mandour, et al.
Published: (2022)

Impact of CDK4/6 Inhibitors on Aromatase Inhibitor-Associated Musculoskeletal Syndrome (AIMSS) in the Adjuvant Setting
by: Efthymia Skafida, et al.
Published: (2023)

A mass balance study of [14C]SHR6390 (dalpiciclib), a selective and potent CDK4/6 inhibitor in humans
by: Hua Zhang, et al.
Published: (2023)

The effects of the Histone Deacetylase (HDAC) Inhibitor 4-Phenylbutyrate on gap junction conductance and permeability
by: Joshua eKaufman, et al.
Published: (2013)

Structure-activity relationship of 7-aryl-2-anilino-pyrrolopyrimidines as Mer and Axl tyrosine kinase inhibitors
by: Shin Hyuck Chung, et al.
Published: (2020)

Discovery of New Uracil and Thiouracil Derivatives as Potential HDAC Inhibitors
by: Omnia R. Elbatrawy, et al.
Published: (2023)

Synthesis and Biological Evaluation of Indole-2-Carboxamides with Potent Apoptotic Antiproliferative Activity as EGFR/CDK2 Dual Inhibitors
by: Lamya H. Al-Wahaibi, et al.
Published: (2022)

Synthesis and Biological Screening of 4-Benzyl-2H-phthalazine Derivatives
by: Ahmed H. Bedair, et al.
Published: (2011)

Design, synthesis and biological evaluation of 4-aminoquinoline derivatives as receptor-interacting protein kinase 2 (RIPK2) inhibitors
by: Tiantian Fan, et al.
Published: (2023)

Design, synthesis, and biological study of 4-[(2-nitroimidazole-1H-alkyloxyl)aniline]-quinazolines as EGFR inhibitors exerting cytotoxicities both under normoxia and hypoxia
by: Cheng W, et al.
Published: (2019)

Synthesis and biological evaluation of quinoxaline derivatives as ASK1 inhibitors
by: Xiaorui Han, et al.
Published: (2024)

Effect of 1,4-naphthoquinone from Sisyrinchium palmifolium L. extract on in vivo Ki-67 expression and in silico CDK1, CDK2, CDK4 on colitis-associated colon cancer
by: Roihatul Muti'ah, et al.
Published: (2022)

Design, Synthesis, In Vitro, and In Silico Studies of New <i>N</i><sup>5</sup>-Substituted-pyrazolo[3,4-<i>d</i>]pyrimidinone Derivatives as Anticancer CDK2 Inhibitors
by: Waheed A. Zaki, et al.
Published: (2023)

An Improved Synthesis Process of Ricolinostat: The First Orally Selective HDAC6 Inhibitor
by: Mengfei Wang, et al.

Synthesis, Antiplasmodial, and Antileukemia Activity of Dihydroartemisinin-HDAC Inhibitor Hybrids as Multitarget Drugs
by: Lukas von Bredow, et al.
Published: (2022)

Clinical potential of novel therapeutic targets in breast cancer: CDK4/6, Src, JAK/STAT, PARP, HDAC, and PI3K/AKT/mTOR pathways
by: Hosford SR, et al.
Published: (2014)

Synthesis and Biological Evaluation of Gentiopicroside Derivatives as Novel Cyclooxygenase-2 Inhibitors with Anti-Inflammatory Activity
by: Ren G, et al.
Published: (2023)

Synthesis and biological evaluation of some 4-aminoquinoline derivatives as potential antitubercular agents
by: Shankar Alegaon, et al.
Published: (2020)